The invention is concerned with novel substituted benzimidazole derivatives of formula (I)
wherein R
1
to R
10
and X are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds bind to FXR and can be used as medicaments.
这项发明涉及式(I)的新型取代
苯并咪唑衍
生物,其中R1至R10和X如描述和权利要求中定义的那样,以及其生理上可接受的盐和
酯。这些化合物与FXR结合,可用作药物。